Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia
BN Savani, K Rezvani, S Mielke, A Montero… - Blood, 2006 - ashpublications.org
Eighty patients with chronic myeloid leukemia (CML) underwent T cell-depleted stem cell
transplantation from an HLA-identical sibling, with add-back of donor T cells on days 30 to …
transplantation from an HLA-identical sibling, with add-back of donor T cells on days 30 to …
Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA …
Between August 1985 and July 1994, we performed 115 volunteer unrelated donor (VUD)
bone marrow transplants (BMT) for first chronic phase (n= 86) or advanced phase (n= 29) …
bone marrow transplants (BMT) for first chronic phase (n= 86) or advanced phase (n= 29) …
Comparative outcomes of T-cell–depleted and non–T-cell–depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor …
LH Sehn, EP Alyea, E Weller, C Canning… - Journal of clinical …, 1999 - ascopubs.org
PURPOSE: Donor lymphocyte infusion (DLI) can restore complete remission in patients with
chronic myelogenous leukemia (CML) who have relapsed after T-cell–depleted (TCD) …
chronic myelogenous leukemia (CML) who have relapsed after T-cell–depleted (TCD) …
Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic …
WR Drobyski, RC Ash, JT Casper, T McAuliffe… - 1994 - ashpublications.org
Abstract Between January 1988 and March 1993, 48 patients received T-cell-depleted
marrow grafts from unrelated donors as treatment for chronic myelogenous leukemia (CML) …
marrow grafts from unrelated donors as treatment for chronic myelogenous leukemia (CML) …
Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and …
We analyzed the incidence of posttransplant chronic myelogenous leukemia (CML) relapse
in 283 consecutive related-donor (n= 177) and unrelated-donor (n= 106) allogeneic …
in 283 consecutive related-donor (n= 177) and unrelated-donor (n= 106) allogeneic …
T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing …
WR Drobyski, MJ Hessner, JP Klein… - Blood, The Journal …, 1999 - ashpublications.org
T-cell depletion (TCD) of the donor marrow graft has been shown to reduce the severity of
graft-versus-host disease (GVHD) in patients with chronic-phase (CP) chronic myelogenous …
graft-versus-host disease (GVHD) in patients with chronic-phase (CP) chronic myelogenous …
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration
PJ Martin, RA Clift, LD Fisher, CD Buckner, JA Hansen… - 1988 - ashpublications.org
Results of HLA-identical allogeneic marrow transplantation were analyzed for 66 patients
with accelerated-phase chronic myelogenous leukemia (CML). Multivariate proportional …
with accelerated-phase chronic myelogenous leukemia (CML). Multivariate proportional …
Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes
JHF Falkenburg, AR Wafelman… - Blood, The Journal …, 1999 - ashpublications.org
Relapse of chronic myeloid leukemia (CML) in chronic phase after allogeneic stem cell
transplantation (SCT) can be successfully treated by donor lymphocyte infusion (DLI) …
transplantation (SCT) can be successfully treated by donor lymphocyte infusion (DLI) …
Improved disease-free–survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients …
AH Elmaagacli, S Basoglu, R Peceny… - Blood, The Journal …, 2002 - ashpublications.org
Outcomes after peripheral blood stem cell transplantation (PBSCT) for chronic phase
chronic myeloid leukemia (n= 37) were compared with outcomes after bone marrow …
chronic myeloid leukemia (n= 37) were compared with outcomes after bone marrow …
Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem …
AH Elmaagacli, R Peceny, N Steckel… - Blood, The Journal …, 2003 - ashpublications.org
Outcomes of highly purified CD34+ peripheral blood stem cell transplantation (PBSCT) for
chronic phase chronic myeloid leukemia (CML)(n= 32) were compared with those of PBSCT …
chronic phase chronic myeloid leukemia (CML)(n= 32) were compared with those of PBSCT …